6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane

C58H60N20O3S2 — CID 158872276

IUPAC6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane
SMILESC.CSc1nc(N)cc(Oc2ccc(-c3nc(Nc4cc(C(C)(C)C)nn4-c4ccc5[nH]ccc5c4)n[nH]3)cc2)n1.CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cc(C(C)(C)C)nn4-c4ccc5[nH]c(=O)ccc5c4)[nH]3)cc2)n1
InChIInChI=1S/C29H28N10O2S.C28H28N10OS.CH4/c1-29(2,3)21-14-23(39(38-21)18-8-11-20-17(13-18)7-12-24(40)31-20)33-27-35-26(36-37-27)16-5-9-19(10-6-16)41-25-15-22(30)32-28(34-25)42-4;1-28(2,3)21-14-23(38(37-21)18-7-10-20-17(13-18)11-12-30-20)32-26-34-25(35-36-26)16-5-8-19(9-6-16)39-24-15-22(29)31-27(33-24)40-4;/h5-15H,1-4H3,(H,31,40)(H2,30,32,34)(H2,33,35,36,37);5-15,30H,1-4H3,(H2,29,31,33)(H2,32,34,35,36);1H4
InChIKeyJBZLKQGUXNKEDC-UHFFFAOYSA-N
MW1149.39 g/mol
LogP12.13
Rot. Bonds14

About 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane

6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane (PubChem CID 158872276) has the molecular formula C58H60N20O3S2 and a molecular weight of 1149.39 g/mol. Its IUPAC name is 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane.

Molecular Properties

Compound Name6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane
PubChem CID158872276
Molecular FormulaC58H60N20O3S2
Molecular Weight1149.39 g/mol
Exact Mass1148.46
IUPAC Name6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane
SMILESC.CSc1nc(N)cc(Oc2ccc(-c3nc(Nc4cc(C(C)(C)C)nn4-c4ccc5[nH]ccc5c4)n[nH]3)cc2)n1.CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cc(C(C)(C)C)nn4-c4ccc5[nH]c(=O)ccc5c4)[nH]3)cc2)n1
InChIInChI=1S/C29H28N10O2S.C28H28N10OS.CH4/c1-29(2,3)21-14-23(39(38-21)18-8-11-20-17(13-18)7-12-24(40)31-20)33-27-35-26(36-37-27)16-5-9-19(10-6-16)41-25-15-22(30)32-28(34-25)42-4;1-28(2,3)21-14-23(38(37-21)18-7-10-20-17(13-18)11-12-30-20)32-26-34-25(35-36-26)16-5-8-19(9-6-16)39-24-15-22(29)31-27(33-24)40-4;/h5-15H,1-4H3,(H,31,40)(H2,30,32,34)(H2,33,35,36,37);5-15,30H,1-4H3,(H2,29,31,33)(H2,32,34,35,36);1H4
InChIKeyJBZLKQGUXNKEDC-UHFFFAOYSA-N
XLogP12.13
TPSA313.55 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds14
Heavy Atoms83
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001149.39
LogP ≤ 512.13
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Analyze 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane?
The IUPAC name of 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane (CID 158872276) is 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane.
What is the SMILES notation for 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane?
The canonical SMILES for 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane is C.CSc1nc(N)cc(Oc2ccc(-c3nc(Nc4cc(C(C)(C)C)nn4-c4ccc5[nH]ccc5c4)n[nH]3)cc2)n1.CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cc(C(C)(C)C)nn4-c4ccc5[nH]c(=O)ccc5c4)[nH]3)cc2)n1.
What is the InChIKey of 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane?
The InChIKey is JBZLKQGUXNKEDC-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H28N10O2S.C28H28N10OS.CH4/c1-29(2,3)21-14-23(39(38-21)18-8-11-20-17(13-18)7-12-24(40)31-20)33-27-35-26(36-37-27)16-5-9-19(10-6-16)41-25-15-22(30)32-28(34-25)42-4;1-28(2,3)21-14-23(38(37-21)18-7-10-20-17(13-18)11-12-30-20)32-26-34-25(35-36-26)16-5-8-19(9-6-16)39-24-15-22(29)31-27(33-24)40-4;/h5-15H,1-4H3,(H,31,40)(H2,30,32,34)(H2,33,35,36,37);5-15,30H,1-4H3,(H2,29,31,33)(H2,32,34,35,36);1H4.
What are the key properties of 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane?
6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane has a molecular weight of 1149.39 g/mol, XLogP of 12.13, 14 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[5-[[5-[4-(6-amino-2-methylsulfanylpyrimidin-4-yl)oxyphenyl]-4H-1,2,4-triazol-3-yl]amino]-3-tert-butylpyrazol-1-yl]-1H-quinolin-2-one;6-[4-[3-[[3-tert-butyl-1-(1H-indol-5-yl)pyrazol-5-yl]amino]-1H-1,2,4-triazol-5-yl]phenoxy]-2-methylsulfanylpyrimidin-4-amine;methane is sourced from PubChem (CID 158872276), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).